SNDX
Syndax Pharmaceuticals Inc

3,764
Mkt Cap
$1.77B
Volume
1.18M
52W High
$21.22
52W Low
$8.58
PE Ratio
-5.63
SNDX Fundamentals
Price
$20.37
Prev Close
$20.41
Open
$20.31
50D MA
$16.67
Beta
1.17
Avg. Volume
2.95M
EPS (Annual)
-$3.72
P/B
15.34
Rev/Employee
$87,703.70
Loading...
Loading...
News
all
press releases
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Moderate Buy" from Analysts
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twelve brokerages that are currently covering the company, MarketBeat.com...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week High - Here's Why
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 1-Year High - Should You Buy...
MarketBeat·2d ago
News Placeholder
Syndax Pharmaceuticals, Inc. $SNDX Shares Acquired by Stempoint Capital LP
Stempoint Capital LP increased its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 48.4% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
Hsbc Holdings PLC Boosts Stock Position in Syndax Pharmaceuticals, Inc. $SNDX
Hsbc Holdings PLC boosted its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 112.4% in the second quarter, according to its most recent filing with the Securities...
MarketBeat·3d ago
News Placeholder
Schroder Investment Management Group Buys 64,598 Shares of Syndax Pharmaceuticals, Inc. $SNDX
Schroder Investment Management Group increased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 112.2% in the second quarter, according to the company in its most...
MarketBeat·6d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 12-Month High - Should You Buy?
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 52-Week High - Still a Buy...
MarketBeat·7d ago
News Placeholder
Syndax Pharmaceuticals, Inc. $SNDX Shares Acquired by Tema Etfs LLC
Tema Etfs LLC increased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 307.7% during the 2nd quarter, according to its most recent filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded Syndax Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·7d ago
News Placeholder
Stonepine Capital Management LLC Buys New Shares in Syndax Pharmaceuticals, Inc. $SNDX
Stonepine Capital Management LLC purchased a new stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the second quarter, according to the company in its most recent 13F...
MarketBeat·8d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 12-Month High - Should You Buy?
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year High - Time to Buy...
MarketBeat·16d ago

Latest SNDX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.